Evidence map›Paper›PMID 39199358›Full record

ReviewBiomolecules2024

Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis.

Yi Chen, Hefang Xiao, Zirui Liu, Fei Teng, Ao Yang, Bin Geng, Xiaoyun Sheng, Yayi Xia

Abstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Advances in sirtuin research in lung diseases (Review).International journal of molecular medicine · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. [Mechanism of sodium valproate in inhibiting ferroptosis of bone marrow mesenchymal stem cells via the adenosine monophosphate-activated protein kinase/Sirtuin 1 axis].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yi ChenDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
Hefang XiaoDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
Zirui LiuDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
Fei TengDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
Ao YangDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
Bin GengDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
Xiaoyun ShengDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.
Yayi XiaDepartment of Orthopedics, Lanzhou University Second Hospital, Lanzhou 730030, China.

Funding

yayi xia The National Natural Science Foundation of China (81960403, 82060405 and 82360436); Lanzhou Science and Technology Plan Program (2021-RC-102); Natural Science Foundation of Gansu Province (22JR5RA943, 22JR5RA956 and 23JRRA1500); Cuiying Scientific and Tec
6 · The paper itself

Abstract

Osteoporosis (OP) is a common metabolic bone disease characterized by low bone mass, decreased bone mineral density, and degradation of bone tissue microarchitecture. However, our understanding of the mechanisms of bone remodeling and factors affecting bone mass remains incomplete. Sirtuin1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent deacetylase that regulates a variety of cellular metabolisms, including inflammation, tumorigenesis, and bone metabolism. Recent studies have emphasized the important role of SIRT1 in bone homeostasis. This article reviews the role of SIRT1 in bone metabolism and OP and also discusses therapeutic strategies and future research directions for targeting SIRT1.

Indexed as

Bone and BonesOsteoporosisSirtuin 1AnimalsBone DensityBone RemodelingHumansSIRT1 protein, humanSirtuin 1bone metabolismosteoporosisSIRT1therapeutic interventions

Identifiers

PMID39199358
PMCPMC11352324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.